Ausgabe 1/2019
Inhalt (20 Artikel)
Current lymphoma diagnostic standards: the pathologists’ view
Magdalena M. Gerlach, Alexandar Tzankov
Therapeutic endoscopic strategies in early esophageal cancer and dysplastic Barrett’s epithelium
Teresa Fritz, Rainer Schöfl, Friedrich Wewalka, Alexander Ziachehabi
Radiochemotherapy in esophageal cancer
Elke Mayer, Christoph Reinhold Arnold, Ute Ganswindt, Robert Jäger
A case report of pseudo-progression after pembrolizumab in metastatic gastric cancer and a review of immunotherapy in gastroesophageal tumors
Hossein Taghizadeh, Katharina Lampichler, Andrea Beer, Matthias Preusser, Aysegul Ilhan-Mutlu
The path of an esophageal carcinoma patient from curative to palliative treatment
Ercan Müldür, Karl Mayrhofer, Wolfgang Hilbe
An update on immunotherapy in breast cancer
Rupert Bartsch, Elisabeth Bergen, Arik Galid
Role of immune checkpoint inhibitors in gastrointestinal cancer treatment
Jakob Michael Riedl, Michael Stotz, Armin Gerger
Changes in patients’ quality of life during radiotherapy and 1 month after treatment
Osamu Tanaka, Yuka Kunishima, Takuya Taniguchi, Kousei Ono, Masayuki Matsuo
Influencing factors on career choice and current occupation analysis of adult survivors of childhood cancer: a special focus on health-related occupations
Istvan-Szilard Szilagy, Eva Nagele, Christine Fürschuß, Andrea Mohapp, Karin Wiegele, Herwig Lackner, Christian Urban
Central nervous system-predominant Erdheim–Chester disease mimicking meningioma responding to BRAF inhibitor therapy: the importance of molecular diagnosis and targeted therapy in rare neoplastic disorders
Amrita Chakrabarti, Anirban Deep Banerjee, Ishani Mohapatra, Ritesh Sachdev, Bosky Jain, Nitin Sood
Kaposi sarcoma following autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia
Utku Iltar, Vedat Aslan, Mesut Gocer, Fatma Aykac, İlknur Nizam, Mehmet Çelik, Faruk Gulec, Turgay Ulaş, Erdal Kurtoğlu